(Q41149388)

27 September 2017

title

In vivo binding affinities of cholecystokinin agonists and antagonists determined using the selective CCKB agonist [3H]pBC 264 (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

28 November 2022

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1797561

28 November 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

28 November 2022

author name string

C. Durieux

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1797561

28 November 2022

M. Ruiz-Gayo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1797561

28 November 2022

B. P. Roques

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1797561

28 November 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

27 September 2017

17 December 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1797561

full work available at URL

28 November 2022

https://api.elsevier.com/content/article/PII:001429999190168P?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

https://api.elsevier.com/content/article/PII:001429999190168P?httpAccept=text/plain

28 November 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

European Journal of Pharmacology

28 November 2022

published in

1 reference

27 September 2017

volume

209

1 reference

27 September 2017

issue

3

1 reference

27 September 2017

page(s)

185-193

1 reference

The role of CCK caerulein, and CCK antagonists in nociception

27 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Antinociceptive profile of sulfated CCK-8. Comparison with CCK-4, unsulfated CCK-8 and other neuropeptides

28 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.

28 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Enzyme-resistant CCK analogs with high affinities for central receptors.

28 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264.

28 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

28 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. II. Solubilization and separation of membrane-bound CCK-8 cleaving enzymes

28 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors

28 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

28 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Occurrence of two cholecystokinin binding sites in guinea-pig brain cortex

28 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Investigation on the metabolism of CCK8 analogues by rat brain slices

28 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Characterization of [3H] CCK4 binding sites in mouse and rat brain

28 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

[3H]pBC 264, first highly potent and very selective radioligand for CCK-B receptors

28 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin

28 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Cholecystokinin decreases food intake in rats.

28 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases

28 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

A behavioural pharmacological study on intracerebroventricularly administered CCK-8 related peptides in mice

28 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat

28 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists

28 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors

28 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

28 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Distinct cholecystokinin receptors in brain and pancreas

28 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Cholecystokinin receptors of A type in the human dorsal medulla oblongata and meningiomas, and of B type in small cell lung carcinomas.

28 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Endopeptidase-24.11 and aminopeptidase activity in brain synaptic membranes are jointly responsible for the hydrolysis of cholecystokinin octapeptide (CCK-8)

28 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Pathway of inactivation of cholecystokinin octapeptide (CCK-8) by synaptosomal fractions

28 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins

28 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Two brain cholecystokinin receptors: implications for behavioral actions

28 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Inhibitory effect of cholecystokinin octapeptide on neurons in the nucleus tractus solitarius

28 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Autoradiography of CCK receptors in the rat brain using [(3)H]Boc[Nle(28)(31)]CCK(27)-(33) and [(125)I]bolton-hunter CCK(8). Functional significance of subregional distributions.

28 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Cholecystokinin and anxiety

28 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice

28 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain

28 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action

28 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

28 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand

28 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.

28 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats

28 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes

28 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Cholecystokinin receptors: presence and axonal flow in the rat vagus nerve

28 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

Autoradiographic localization of cholecystokinin receptors in rodent brain

28 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90168-P

28 November 2022

Identifiers

1 reference

27 September 2017

1 reference